Literature DB >> 2479645

Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus.

J R Glenney1.   

Abstract

Recent studies from this laboratory have identified novel cytoskeletal proteins that are phosphorylated on tyrosine in vivo in Rous sarcoma virus-transformed chick fibroblasts (Glenney, J. R., Jr., and Zokas, L. (1989) J. Cell Biol. 108, 2401-2408). In the present report, the phosphorylation of these proteins was examined in cells expressing the nonmyristylated mutants of src that are not transformed. A good correlation was found between transformation and the tyrosine phosphorylation of a 22-kDa protein. Tyrosine phosphorylation of the 22-kDa protein was reduced more than 95% in cells expressing the nonmyristylated mutants of src. Size fractionation revealed that the 22-kDa phosphoprotein in transformed chick fibroblasts is found in a Mr 150,000 complex. Monoclonal antibodies were used to screen various chicken tissues where the 22-kDa protein was found at high levels in muscle and lung with low levels in epithelial cells and brain. The 22-kDa protein becomes an excellent candidate for a mediator of transformation by the tyrosine kinase class of oncogenes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479645

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  97 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton.

Authors:  M Stahlhut; B van Deurs
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells.

Authors:  Marie-Odile Parat; Rafal Z Stachowicz; Paul L Fox
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 4.  Cellular endocytosis and gene delivery.

Authors:  Jennifer E Ziello; Yan Huang; Ion S Jovin
Journal:  Mol Med       Date:  2010-02-03       Impact factor: 6.354

Review 5.  Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules.

Authors:  Guochang Hu; Aaron T Place; Richard D Minshall
Journal:  Chem Biol Interact       Date:  2007-08-15       Impact factor: 5.192

Review 6.  Bidirectional control of the inner dynamics of focal adhesions promotes cell migration.

Authors:  Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2009-04-30       Impact factor: 3.405

7.  CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.

Authors:  Kei Ohnuma; Tadanori Yamochi; Masahiko Uchiyama; Kunika Nishibashi; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Hirotoshi Tanaka; Nam H Dang; Chikao Morimoto
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Src-mediated caveolin-1 phosphorylation regulates intestinal epithelial restitution by altering Ca(2+) influx after wounding.

Authors:  Navneeta Rathor; Ran Zhuang; Jian-Ying Wang; James M Donahue; Douglas J Turner; Jaladanki N Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-20       Impact factor: 4.052

9.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Authors:  F Galbiati; D Volonte; J A Engelman; G Watanabe; R Burk; R G Pestell; M P Lisanti
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.